Home TMU Sitemap FAQ Links
正體中文
Home Ongoing Clinical Trials
Ongoing Clinical Trials

Institution
Principal Investigator
Protocol Title
Keyword
TMU-JIRB No. Protocol Title Institution / Principal Investigator dictionary.testing.TypeOfStudy dictionary.testing.PhasesOfClinicalTrialsForDrugs
N202507047 A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL) New Drug Phase Ⅲ
N202507061 A Phase I Open-Label Study to Assess the Safety and Tolerability of Allogenic Human Umbilical Mesenchymal Stem Cell Therapy for Patients with Alzheimer's Disease New Drug Phase Ⅰ
N202507065 【Innovative Medical Device Research】Development and Validation of AI-driven Task-Oriented Digital Cognitive Assessment System New Medical Device NA
N202507066 Clinical Study on the Use of LDCT Imaging to Assess Coronary Artery Calcification for Therapeutic Decision-Making in ASCVD Management New Medical Device NA
N202507077 Clinical Implementation and Process Integration of Home-Based Interactive Respiratory Monitoring and Lung Rehabilitation System: Construction and Feasibility Verification of a Digital Tracking Platform for Hospitals New Medical Device NA
N202507078 A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL) New Drug Phase Ⅲ
N202507107 Development of an Auricular Vagus Nerve Stimulator for the Treatment of Overactive Bladder New Medical Device NA
N202507109 A Phase 2 Study to Assess ADX 038 in Participants With Complement-Mediated Kidney Disease
TMUH / I-Wen Wu
New Drug Phase Ⅱ
N202507112 TSVoice smart transnasal voice prothesis New Medical Device NA
1 2 29 30 31 32 33 34 35 51 52 / 52

TOP